ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Innophos Holdings has paid $46 million for Triarco Industries, a privately held maker of botanical and enzyme-based nutritional ingredients with annual sales of about $25 million. The acquisition adds to a specialty ingredients operation that Innophos built with the purchase of chelated minerals maker AMT in 2012 and micronutrients maker Kelatron in 2011. Innophos says the new deal continues its strategy of expansion into categories related to its core specialty phosphate business.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter